Turn Gov't Ideas into Profits with New Licenses
Published Date: 6/16/2025
Notice
Summary
The U.S. Government owns some cool inventions and is ready to license them out so companies can bring them to market faster. This means businesses can grab rights to use these inventions, including some with international patent protection. If you’re a company looking to innovate, now’s the time to check out these opportunities and get in on the action!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Government Inventions Available to License
If you run a company or are starting a business, the U.S. Government is offering rights to use certain government-owned inventions so firms can commercialize results of federally funded research and development. These inventions are available for licensing to help companies bring products to market faster.
Selected Inventions May Have Foreign Patents
Some of the listed inventions have foreign patent applications filed to extend market coverage, and those foreign-protected inventions may also be available for licensing. If you are a company seeking international rights, selected inventions with foreign patent filings could be licensed to you.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10310 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting
The National Institute on Deafness and Other Communication Disorders is holding a private virtual meeting on July 20, 2026, to review grant applications. This meeting affects researchers seeking funding for projects related to hearing and communication disorders. No public access is allowed to protect sensitive information, and the decisions could impact future research funding.
2026-10231 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on June 25, 2026, to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants should note the date, as these reviews impact who gets money for their work.
2026-10175 — Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a private virtual meeting on June 9, 2026, to review grant applications about infectious diseases and immunology. This closed session protects sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as this review impacts funding decisions.
2026-09947 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting health science projects. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10022 — Submission for OMB Review; 30-Day Comment Request; Early Career Reviewer Program Online Application and Vetting System (Center for Scientific Review)
The NIH wants your thoughts on their Early Career Reviewer Program’s new online application and review system. This affects early career scientists applying to review research, making the process smoother and digital. You’ve got 30 days to share your feedback—no cost changes, just a smarter way to apply!
2026-10021 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate grant applications related to health and cancer research. These meetings are private to protect sensitive information and personal privacy. Researchers applying for grants and NIH staff are the main players, with no direct cost changes announced but important deadlines to keep in mind.
Previous / Next Documents
Previous: 2025-10920 — Government-Owned Inventions; Availability for Licensing
The U.S. Government owns some cool inventions and is ready to license them out so businesses can bring them to market faster. This means companies, big or small, can grab a chance to use these inventions, including some with international patent protection. If you’re interested, now’s the time to act and turn these government-backed ideas into real products!
Next: 2025-10922 — Abbreviated New Drug Applications: Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions; Guidance for Industry; Availability
The FDA just released new rules to help generic drug makers send important info about their factories before submitting priority drug applications. This speeds up reviews and helps the FDA set clear goals for fast-tracking these drugs. If you’re in the generic drug business, get ready to share your facility details early to keep things moving smoothly and meet new deadlines tied to the latest fee program.